High-throughput assessment of mechanical properties of stem cell derived red blood cells, toward cellular downstream processing
Guzniczak, Ewa and Mohammad Zadeh, Maryam and Dempsey, Fiona and Jimenez, Melanie and Bock, Henry and Whyte, Graeme and Willoughby, Nicholas and Bridle, Helen (2017) High-throughput assessment of mechanical properties of stem cell derived red blood cells, toward cellular downstream processing. Scientific Reports, 7 (1). 14457. ISSN 2045-2322 (https://doi.org/10.1038/s41598-017-14958-w)
Preview |
Text.
Filename: Guzniczak-etal-SR-2017-High-throughput-assessment-of-mechanical-properties-of-stem-cell.pdf
Final Published Version License: Download (2MB)| Preview |
Abstract
Stem cell products, including manufactured red blood cells, require efficient sorting and purification methods to remove components potentially harmful for clinical application. However, standard approaches for cellular downstream processing rely on the use of specific and expensive labels (e.g. FACS or MACS). Techniques relying on inherent mechanical and physical properties of cells offer high-throughput scalable alternatives but knowledge of the mechanical phenotype is required. Here, we characterized for the first time deformability and size changes in CD34+ cells, and expelled nuclei, during their differentiation process into red blood cells at days 11, 14, 18 and 21, using Real-Time Deformability Cytometry (RT-DC) and Atomic Force Microscopy (AFM). We found significant differences (p < 0.0001; standardised mixed model) between the deformability of nucleated and enucleated cells, while they remain within the same size range. Expelled nuclei are smaller thus could be removed by size-based separation. An average Young's elastic modulus was measured for nucleated cells, enucleated cells and nuclei (day 14) of 1.04 ± 0.47 kPa, 0.53 ± 0.12 kPa and 7.06 ± 4.07 kPa respectively. Our identification and quantification of significant differences (p < 0.0001; ANOVA) in CD34+ cells mechanical properties throughout the differentiation process could enable development of new routes for purification of manufactured red blood cells.
-
-
Item type: Article ID code: 90134 Dates: DateEvent31 October 2017Published18 October 2017AcceptedSubjects: Medicine > Biomedical engineering. Electronics. Instrumentation Department: Faculty of Engineering > Biomedical Engineering Depositing user: Pure Administrator Date deposited: 05 Aug 2024 13:36 Last modified: 05 Aug 2024 13:36 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/90134